MULTIPLE SYSTEM ATROPHY
Clinical trials for MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to slow rare brain disease
Disease control Not yet recruitingThis early-phase study tests a new drug called ALT001 in 60 people with multiple system atrophy (MSA), a rare brain disease that affects movement and automatic body functions. The main goals are to check if the drug is safe and to see if it can help control symptoms. Participants…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: EARLY_PHASE1 • Sponsor: yilong Wang • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Could a common stroke drug help slow multiple system atrophy?
Symptom relief Not yet recruitingThis study tests whether a drug called butylphthalide can help control symptoms of multiple system atrophy (MSA), a rare brain disorder that affects movement and automatic body functions. About 150 adults aged 30 to 80 with early-stage MSA will take either the drug or a placebo f…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 26, 2026 06:58 UTC
-
Can a simple test tell Parkinson's from look-alike diseases?
Knowledge-focused Not yet recruitingThis study aims to find biological markers in blood, urine, and stool that can help doctors distinguish Parkinson's disease from other similar brain disorders early on. Researchers will study 200 adults aged 40-80 with early symptoms, plus healthy volunteers, over 12-18 months. W…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: International Institute of Molecular and Cell Biology in Warsaw • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC